Business · 11/04/2013Updated: 10/17/2026 · 1 min read
FDA Announces Disease Areas for Patient-Focused Drug Development Meetings
Summary
The FDA is selecting disease areas to be addressed during the first 3 years of Patient-Focused Drug Development, a 5-year initiative to gather patients' input on specific conditions and therapies.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →